CompletedNot Applicable

Impact of Sarcopenia on Postoperative Outcomes of Patients Undergoing Liver Resection

Italy251 participantsStarted 2018-07-01

Plain-language summary

The investigators will investigate the impact of different biometric parameters (Body mass index, sarcopenia, lean muscle mass, hand-grip strength, gait speed, fat composition) on the postoperative outcomes of patients undergoing liver resections. Major and minor liver resections will be considered as well as open and minimally invasive techniques. Benign and malignant indications will be included. Patients characteristics and perioperative variables will be considered for analysis. Short-term outcomes will be evaluated focusing on 90-days morbidity and mortality and readmission rate.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients undergoing open or laparoscopic liver resection
✓. Patients undergoing major or minor liver resection
✓. Patients undergoing liver resection for primary or secondary liver malignancies
✓. Patients undergoing liver resections for benign diseases (cysts, adenoma, focal nodular hyperplasia, hemangioma) -

Exclusion criteria

✕. Patients undergoing extrahepatic resection
✕. Patients undergoing cyst fenestration or biopsies without liver resections
✕. Patients with extrahepatic metastases
✕. Patients undergoing explorative laparoscopy or laparotomy without parenchymal transection -

What they're measuring

Morbidity

Timeframe: within 90 days after surgery

Trial details

NCT IDNCT03630978

SponsorSan Camillo Hospital, Rome

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2019-12-20

View on ClinicalTrials.gov More Liver Neoplasms trials